Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein
The urgent need for vaccines against Ebola virus (EBOV) was underscored by the large outbreak in West Africa (2014–2016). Since then, several promising vaccine candidates have been tested in pre-clinical and clinical studies. As a result, two vaccines were approved for human use in 2019/2020, of...
Sábháilte in:
Príomhchruthaitheoirí: | , , , , , , , , |
---|---|
Formáid: | Alt |
Teanga: | Béarla |
Foilsithe / Cruthaithe: |
Philipps-Universität Marburg
2023
|
Ábhair: | |
Rochtain ar líne: | An téacs iomlán mar PDF |
Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Ar líne
An téacs iomlán mar PDFGairmuimhir: |
urn:nbn:de:hebis:04-es2023-00054 |
---|---|
Dáta a fhoilsithe: |
2023-03-06 |
Foinse: |
Erstveröffentlichung: Kupke, A.; Volz, A.; Dietzel, E.; Freudenstein, A.; Schmidt, J.; Shams-Eldin, H.; Jany, S.; Sauerhering, L.; Krähling, V.; Gellhorn Serra, M.; et al. Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein. Vaccines 2022, 10, 533. https://doi.org/10.3390/vaccines10040533 |
Downloads: |
32 (2024), 32 (2023) |
Lizenz: |
https://creativecommons.org/licenses/by/4.0 |
URL Rochtana: |
https://archiv.ub.uni-marburg.de/es/2023/0005 https://doi.org/10.3390/vaccines10040533 |